CONDUIT PHARMACEUTICALS INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2022 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Conduit Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2022 to Q3 2024.
  • Conduit Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 87.2M shares, a 31.8% increase year-over-year.
  • Conduit Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 67.9M shares, a 81.3% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 87.2M +21M +31.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 73.9M +8.03M +12.2% Apr 1, 2024 Jun 30, 2024 10-Q/A 2024-11-14
Q1 2024 73.8M +9.2M +14.2% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-11-14
Q4 2023 67.9M Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 66.1M +33.8M +105% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 65.8M Apr 1, 2023 Jun 30, 2023 10-Q/A 2024-11-14
Q1 2023 64.6M Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-11-14
Q3 2022 32.3M Jul 1, 2022 Sep 30, 2022 10-Q/A 2023-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.